News

Scientists have discovered how chemokines and G protein-coupled receptors selectively bind each other to control how cells move.
Repertoire Immune Medicines has signed a partnership and licence agreement with Genentech, focusing on T cell-targeted immune ...
Stimulating a receptor in adipocytes enhanced energy expenditure and caused sustained weight loss in mice, offering targets ...
Irritable bowel syndrome, chronic itching, asthma and migraine are in many cases hard-to-treat conditions. They have in common that they are triggered by an excessive immune response -- which in ...
A protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells plays a surprising, ...
Scientists from St. Jude Children's Research Hospital and the Medical College of Wisconsin have created a data science framework to better understand how cells travel through the body.
Growing microplastic pollution poses health risks, but new research offers hope. A study reveals that colorful fruits and ...
The AERIAL trial will assess LEU011, which has MHRA Innovation Passport status, for solid tumors, a challenging area compared ...
During a live event, Jack Khouri, MD, discussed options for patients with multiple myeloma after relapse and choices to ...
Scientists from St. Jude Children's Research Hospital and the Medical College of Wisconsin have created a data science ...
Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these ...
Houston, Texas and Tuebingen, Germany, April 23, 2025 - Immatics N.V.(NASDAQ: IMTX, "Immatics" or the "Company"), a clinical-stage biopharmaceutical company active in the discovery and development of ...